Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

4 mins

Kateki Vinod, AGS 2022: Tubes and Trabs for the Treatment of Glaucoma

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Apr 11th 2022

It was a pleasure to speak with Dr Kateki Vinod (New York Eye and Ear Infirmary of Mount Sinai, New York, NY, USA) on surgical options for glaucoma and the future of tubes and trabs.

The presentation entitled ‘ Head to Head Surgical Trials: Tubes and Trabs’ was presented at the 2022 American Glaucoma Society Annual Meeting, March 03-06, 2022

Questions:

  1. What factors should be considered when choosing surgical options for glaucoma? (00:17)
  2. With the increasing popularity of MiGS, where do you see the future of tubes and trabs?(02:20)

Disclosures: Kateki Vinod has nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Shanice Allen.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup